SVP, Finance at Triumvira Immunologics
Mr. Jon Irvin joined Triumvira as the Vice President of Finance in January 2018. Prior to Triumvira, Mr. Irvin was the Chief Financial Officer and Vice President of Finance at Mirna Therapeutics. He also served as the Chief Executive Officer and Vice President of Finance for Voxpath Networks, Inc., a telecommunications and intellectual property company. Previously, Mr. Irvin was in executive financial positions at Reddwerks Corporation, a software company, Esoterix, Inc., a medical laboratory company, Topaz Technologies, a pharmaceutical software company, and BioNumerik Pharmaceuticals, Inc., a pharmaceutical company. Mr. Irvin began his career as an accountant with Price Waterhouse (senior) and Ernst & Young (senior manager). He received a B.S. in Accounting from the University of Illinois, and his Certified Public Accountant designation in California.
Vice President, Finance